Shivalik Rasayan Ltd.

270.490.59%

2026-08-21

shivalikrasayan.comBSE: 539148NSE: SHIVALIK
Market Cap₹ 422 Cr.
Current Price₹ 270
High / Low₹ 522 / 206
Stock P/E0.0
Book Value₹ 240
Price to Book2.68
Dividend Yield0.19 %
ROCE4.7 %
ROE3.8 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Latest quarter profit grew 117.6% YoY, showing strong momentum
  • Company has delivered good sales growth of 19.7% CAGR over last 5 years
  • Working capital cycle has improved - days down from 252 to 129
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Operating cash flow has been negative in recent years
  • Company has a low return on capital employed of 4.6%
  • Company has a low return on equity of 4.1% over last 3 years
  • Recent results are weak - TTM profit is down 12.4% versus prior year
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.40x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.UPL570.8023.8548185.181.05-73.0058.5210181.0010.4712.0013.43
2.PIIND2489.5032.4237770.230.60244.20-38.951702.30-10.4316.0021.69
3.SUMICHEM551.8047.5327542.860.24214.5120.451063.350.6223.3921.94
4.BAYERCROP4068.85330.0218286.263.69321.6015.391835.00-4.1630.0820.03
5.SHARDACROP763.4011.006887.431.9688.02-38.361073.779.0331.1017.32
6.DHANUKA995.0014.944435.540.2075.5027.94442.0220.0124.4424.83
7.RALLIS212.7525.204137.331.41-14.15-274.26507.547.7013.23-0.56
8.NACLIND170.00321.923982.140.0020.8459.82383.33-14.506.2010.80
9.BHAGCHEM283.20133.423672.230.05133.293249.841950.191475.554.5515.65
10.GSPCROP590.2528.052745.770.17263.941111.463859.951153.2720.8111.02
11.BHARATRAS1300.9515.092162.320.04372.30838.733381.60796.0316.6315.19
12.SHIVALIK267.7530.85421.720.194.5059.5596.347.877.6911.61
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
23
18
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
1
3
Tax %
10.25%
Net Profit
3
2
Equity Capital
7
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
7
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
24
18
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
2
2
Tax %
50.21%
Net Profit
1
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
24
20
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
1
2
Tax %
7.60%
Net Profit
2
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
24
20
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
1
2
Tax %
-6.67%
Net Profit
3
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
32
26
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
2
3
Tax %
-0.66%
Net Profit
3
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
38
31
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
2
3
Tax %
-13.44%
Net Profit
3
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
40
34
Operating Profit
OPM %
Other Income
1
Interest
2
Depreciation
3
4
Tax %
-1.78%
Net Profit
4
3
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
40
32
Operating Profit
OPM %
Other Income
0
Interest
2
Depreciation
2
3
Tax %
4.58%
Net Profit
3
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
46
40
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
2
Tax %
39.60%
Net Profit
1
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
47
40
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
3
Tax %
21.51%
Net Profit
2
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
35
29
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
3
2
Tax %
-0.99%
Net Profit
2
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
42
35
Operating Profit
OPM %
Other Income
0
Interest
2
Depreciation
2
3
Tax %
-2.25%
Net Profit
3
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
48
45
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
3
Tax %
13.99%
Net Profit
3
0
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
43
38
Operating Profit
5
OPM %
13
Other Income
1
Interest
1
Depreciation
0
4
Tax %
33
Net Profit
3
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2017
41
34
Operating Profit
7
OPM %
18
Other Income
1
Interest
2
Depreciation
0
5
Tax %
33
Net Profit
3
EPS
0
Dividend Payout %
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2018
44
36
Operating Profit
8
OPM %
18
Other Income
1
Interest
1
Depreciation
0
6
Tax %
19
Net Profit
5
EPS
0
Dividend Payout %
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Mar 2019
48
42
Operating Profit
11
OPM %
22
Other Income
4
Interest
1
Depreciation
1
9
Tax %
-3
Net Profit
9
EPS
0
Dividend Payout %
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2020
61
51
Operating Profit
11
OPM %
18
Other Income
1
Interest
1
Depreciation
1
9
Tax %
-0
Net Profit
9
EPS
0
Dividend Payout %
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2021
85
66
Operating Profit
19
OPM %
23
Other Income
0
Interest
1
Depreciation
6
13
Tax %
-1
Net Profit
13
EPS
9
Dividend Payout %
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
9
Minority Interest
0
Share of Associates
0
Adjusted EPS
9
Mar 2022
99
76
Operating Profit
25
OPM %
25
Other Income
2
Interest
1
Depreciation
5
19
Tax %
-3
Net Profit
19
EPS
14
Dividend Payout %
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
13
Minority Interest
0
Share of Associates
0
Adjusted EPS
13
Mar 2023
94
74
Operating Profit
21
OPM %
23
Other Income
2
Interest
1
Depreciation
5
15
Tax %
-3
Net Profit
15
EPS
10
Dividend Payout %
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Mar 2024
94
77
Operating Profit
19
OPM %
20
Other Income
2
Interest
3
Depreciation
5
10
Tax %
15
Net Profit
9
EPS
6
Dividend Payout %
9
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2025
149
123
Operating Profit
29
OPM %
19
Other Income
2
Interest
6
Depreciation
9
14
Tax %
-3
Net Profit
14
EPS
9
Dividend Payout %
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
9
Minority Interest
0
Share of Associates
0
Adjusted EPS
9
TTM
172
150
Operating Profit
OPM %
Other Income
1
Interest
6
Depreciation
11
11
Tax %
9
Net Profit
10
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
14%
5 Years:
20%
3 Years:
15%

COMPOUNDED PROFIT GROWTH

10 Years:
23%
5 Years:
10%
3 Years:
-11%

STOCK PRICE CAGR

10 Years:
5 Years:
3 Years:
-30%
1 Year:
-47%

RETURN ON EQUITY

10 Years:
11%
5 Years:
6%
3 Years:
4%
Last Year:
4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2018

Apr 19

1:4

Bonus issue & Stock Split Inter alia, to consider and approve, subject to requisite approvals: 1. Sub-division of Equity Shares of the Company; 2. Alteration of the Authorised Share Capital of the Company; 3. Alteration of the Memorandum and Articles of the Company in accordance with the Companies Act, 2013; 4. Issue of Bonus Shares to the Shareholders of the Company; 5. Diversification of the business of the Company in Pharmaceuticals and Speciality Chemicals and resulting alteration in the main objects of the Company; 6. Setting up a US FDA & EU level state of art Pharmaceuticals API & Intermediates manufacturing plant in Dahej, Gujarat; 7. Raising of funds by way of fresh issue of equity shares through preferential / rights / public offer/ institutional placement and Loans, as may be deemed fit for setting up the said Pharmaceuticals API & Intermediates manufacturing plant in Dahej, Gujarat; 8. Appointment of Dr. Akshay Kant Chaturvedi as an Executive Director on the Board of the Company 9. Appointment of Mr. Sanjay Bansal as Director on the Board of the Company; 10. Resignation of Mr. Rajiv Mehta from the Directorship of the Company; 11. Re-classification of M/s. NIAM International Private Limited as non-promoter entity, for which the Company has received a request letter dated February 24, 2018 from the said shareholder; and 12. To consider seeking approval of the Shareholders of the Company through postal ballot for the requisite items referred above. Further, pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of the "Code of Conduct for prevention of Insider Trading" of the Company, the trading window shall remain closed from Monday, February 26, 2018 to Tuesday, March 06, 2018 (both days inclusive) for the Directors and specified persons as defined in the Code of Conduct.

Mar 2016
Equity Capital
3
10
1
Trade Payables
10
12
Total Liabilities
37
8
Capital Work in Progress
0
16
1
0
Cash & Bank
1
11
Total Assets
37
Total Debt
11
Net Working Capital
-5
Contingent Liabilities
0
Book Value per Share
38.04
Face Value
10.00
Total Debt
11
Net Working Capital
-5
Contingent Liabilities
0
Book Value per Share
38.04
Face Value
10.00
Mar 2017
Equity Capital
3
14
0
Trade Payables
5
16
Total Liabilities
38
8
Capital Work in Progress
0
18
1
0
Cash & Bank
2
9
Total Assets
38
Total Debt
14
Net Working Capital
-2
Contingent Liabilities
0
Book Value per Share
47.66
Face Value
10.00
Total Debt
14
Net Working Capital
-2
Contingent Liabilities
0
Book Value per Share
47.66
Face Value
10.00
Mar 2018
Equity Capital
4
42
0
Trade Payables
5
10
Total Liabilities
61
15
Capital Work in Progress
0
27
3
0
Cash & Bank
4
13
Total Assets
61
Total Debt
8
Net Working Capital
8
Contingent Liabilities
0
Book Value per Share
107.93
Face Value
10.00
Total Debt
8
Net Working Capital
8
Contingent Liabilities
0
Book Value per Share
107.93
Face Value
10.00
Mar 2019
Equity Capital
7
153
2
Trade Payables
7
10
Total Liabilities
178
16
Capital Work in Progress
11
27
6
0
Cash & Bank
86
32
Total Assets
178
Total Debt
9
Net Working Capital
107
Contingent Liabilities
0
Book Value per Share
113.65
Face Value
5.00
Total Debt
9
Net Working Capital
107
Contingent Liabilities
0
Book Value per Share
113.65
Face Value
5.00
Mar 2020
Equity Capital
7
161
0
Trade Payables
14
4
Total Liabilities
186
18
Capital Work in Progress
61
39
3
0
Cash & Bank
6
59
Total Assets
186
Total Debt
0
Net Working Capital
40
Contingent Liabilities
0
Book Value per Share
116.25
Face Value
5.00
Total Debt
0
Net Working Capital
40
Contingent Liabilities
0
Book Value per Share
116.25
Face Value
5.00
Mar 2021
Equity Capital
7
173
7
Trade Payables
12
24
Total Liabilities
222
120
Capital Work in Progress
0
53
5
0
Cash & Bank
1
43
Total Assets
222
Total Debt
11
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
125.86
Face Value
5.00
Total Debt
11
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
125.86
Face Value
5.00
Mar 2022
Equity Capital
7
256
11
Trade Payables
12
30
Total Liabilities
317
128
Capital Work in Progress
3
55
11
0
Cash & Bank
67
52
Total Assets
317
Total Debt
15
Net Working Capital
83
Contingent Liabilities
0
Book Value per Share
177.33
Face Value
5.00
Total Debt
15
Net Working Capital
83
Contingent Liabilities
0
Book Value per Share
177.33
Face Value
5.00
Mar 2023
Equity Capital
7
271
21
Trade Payables
18
46
Total Liabilities
363
126
Capital Work in Progress
57
65
30
0
Cash & Bank
10
76
Total Assets
363
Total Debt
40
Net Working Capital
43
Contingent Liabilities
0
Book Value per Share
184.19
Face Value
5.00
Total Debt
40
Net Working Capital
43
Contingent Liabilities
0
Book Value per Share
184.19
Face Value
5.00
Mar 2024
Equity Capital
8
363
23
Trade Payables
13
63
Total Liabilities
470
122
Capital Work in Progress
117
73
42
31
Cash & Bank
23
61
Total Assets
470
Total Debt
55
Net Working Capital
65
Contingent Liabilities
0
Book Value per Share
228.62
Face Value
5.00
Total Debt
55
Net Working Capital
65
Contingent Liabilities
0
Book Value per Share
228.62
Face Value
5.00
Mar 2025
Equity Capital
8
390
48
Trade Payables
24
39
Total Liabilities
508
250
Capital Work in Progress
0
74
56
27
Cash & Bank
24
77
Total Assets
508
Total Debt
71
Net Working Capital
53
Contingent Liabilities
3
Book Value per Share
233.62
Face Value
5.00
Total Debt
71
Net Working Capital
53
Contingent Liabilities
3
Book Value per Share
233.62
Face Value
5.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
6
Cash from Investing
-17
Cash from Financing
7
-4
Free Cash Flow
5
OCF / Net Profit
2.32
Cumulative 5-Year FCF
0
OCF / Net Profit
2.32
Cumulative 5-Year FCF
0
Mar 2017
4
Cash from Investing
-2
Cash from Financing
-2
1
Free Cash Flow
4
OCF / Net Profit
1.36
Cumulative 5-Year FCF
0
OCF / Net Profit
1.36
Cumulative 5-Year FCF
0
Mar 2018
-2
Cash from Investing
-16
Cash from Financing
19
2
Free Cash Flow
-8
OCF / Net Profit
-0.31
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.31
Cumulative 5-Year FCF
0
Mar 2019
-12
Cash from Investing
-9
Cash from Financing
104
83
Free Cash Flow
-25
OCF / Net Profit
-1.35
Cumulative 5-Year FCF
0
OCF / Net Profit
-1.35
Cumulative 5-Year FCF
0
Mar 2020
-7
Cash from Investing
-65
Cash from Financing
-9
-81
Free Cash Flow
-60
OCF / Net Profit
-0.81
Cumulative 5-Year FCF
-85
OCF / Net Profit
-0.81
Cumulative 5-Year FCF
-85
Mar 2021
46
Cash from Investing
-61
Cash from Financing
10
-5
Free Cash Flow
-1
OCF / Net Profit
3.63
Cumulative 5-Year FCF
-91
OCF / Net Profit
3.63
Cumulative 5-Year FCF
-91
Mar 2022
7
Cash from Investing
-16
Cash from Financing
76
66
Free Cash Flow
-9
OCF / Net Profit
0.36
Cumulative 5-Year FCF
-104
OCF / Net Profit
0.36
Cumulative 5-Year FCF
-104
Mar 2023
-13
Cash from Investing
-65
Cash from Financing
21
-57
Free Cash Flow
-69
OCF / Net Profit
-0.84
Cumulative 5-Year FCF
-165
OCF / Net Profit
-0.84
Cumulative 5-Year FCF
-165
Mar 2024
-1
Cash from Investing
-69
Cash from Financing
83
13
Free Cash Flow
-62
OCF / Net Profit
-0.16
Cumulative 5-Year FCF
-202
OCF / Net Profit
-0.16
Cumulative 5-Year FCF
-202
Mar 2025
-1
Cash from Investing
-20
Cash from Financing
22
1
Free Cash Flow
-20
OCF / Net Profit
-0.08
Cumulative 5-Year FCF
-162
OCF / Net Profit
-0.08
Cumulative 5-Year FCF
-162

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
EPS (₹)
7.80
Book Value (₹)
38.04
Dividend per Share (₹)
0.00
Cash EPS (₹)
3.56
Operating Margin %
11.31%
Net Margin %
5.57%
ROE %
22.87%
ROCE %
28.94%
8.92%
Debtor Days
62
Inventory Days
5
Payable Days
137
-70
Debt to Equity (x)
0.85x
Interest Coverage (x)
4.78x
0.67x
Revenue Growth %
3.13%
Operating Profit Growth %
66.96%
Net Profit Growth %
47.73%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
9.65
Book Value (₹)
47.66
Dividend per Share (₹)
1.00
Cash EPS (₹)
4.30
Operating Margin %
15.84%
Net Margin %
7.17%
ROE %
22.52%
ROCE %
25.44%
8.76%
Debtor Days
49
Inventory Days
9
Payable Days
115
-56
Debt to Equity (x)
0.86x
Interest Coverage (x)
3.51x
0.81x
Revenue Growth %
-3.88%
Operating Profit Growth %
34.57%
Net Profit Growth %
23.64%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
12.20
Book Value (₹)
107.93
Dividend per Share (₹)
1.00
Cash EPS (₹)
5.21
Operating Margin %
17.80%
Net Margin %
11.39%
ROE %
16.64%
ROCE %
18.44%
10.33%
Debtor Days
52
Inventory Days
16
Payable Days
66
2
Debt to Equity (x)
0.17x
Interest Coverage (x)
5.86x
2.05x
Revenue Growth %
6.57%
Operating Profit Growth %
10.04%
Net Profit Growth %
55.58%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
6.47
Book Value (₹)
113.65
Dividend per Share (₹)
0.50
Cash EPS (₹)
7.06
Operating Margin %
22.09%
Net Margin %
18.59%
ROE %
8.83%
ROCE %
8.96%
7.45%
Debtor Days
62
Inventory Days
34
Payable Days
76
20
Debt to Equity (x)
0.05x
Interest Coverage (x)
8.65x
9.26x
Revenue Growth %
9.90%
Operating Profit Growth %
31.98%
Net Profit Growth %
73.61%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
6.35
Book Value (₹)
116.25
Dividend per Share (₹)
0.25
Cash EPS (₹)
7.09
Operating Margin %
17.55%
Net Margin %
14.40%
ROE %
5.53%
ROCE %
5.93%
4.80%
Debtor Days
51
Inventory Days
28
Payable Days
111
-32
Debt to Equity (x)
0.00x
Interest Coverage (x)
10.26x
3.18x
Revenue Growth %
26.75%
Operating Profit Growth %
0.69%
Net Profit Growth %
-1.81%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
9.20
Book Value (₹)
125.86
Dividend per Share (₹)
0.50
Cash EPS (₹)
13.60
Operating Margin %
22.53%
Net Margin %
14.94%
ROE %
7.60%
ROCE %
7.57%
6.20%
Debtor Days
53
Inventory Days
17
Payable Days
129
-59
Debt to Equity (x)
0.07x
Interest Coverage (x)
24.81x
1.05x
Revenue Growth %
39.65%
Operating Profit Growth %
79.29%
Net Profit Growth %
44.82%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
13.36
Book Value (₹)
177.33
Dividend per Share (₹)
0.50
Cash EPS (₹)
16.97
Operating Margin %
25.40%
Net Margin %
19.49%
ROE %
9.00%
ROCE %
8.56%
7.18%
Debtor Days
42
Inventory Days
29
Payable Days
107
-36
Debt to Equity (x)
0.06x
Interest Coverage (x)
17.82x
3.04x
Revenue Growth %
17.01%
Operating Profit Growth %
31.90%
Net Profit Growth %
52.70%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
10.42
Book Value (₹)
184.19
Dividend per Share (₹)
0.50
Cash EPS (₹)
14.04
Operating Margin %
22.77%
Net Margin %
16.14%
ROE %
5.77%
ROCE %
5.34%
4.44%
Debtor Days
51
Inventory Days
80
Payable Days
130
1
Debt to Equity (x)
0.15x
Interest Coverage (x)
11.06x
1.70x
Revenue Growth %
-5.76%
Operating Profit Growth %
-15.53%
Net Profit Growth %
-21.96%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
5.55
Book Value (₹)
228.62
Dividend per Share (₹)
0.50
Cash EPS (₹)
8.95
Operating Margin %
18.28%
Net Margin %
9.22%
ROE %
2.77%
ROCE %
3.68%
2.07%
Debtor Days
99
Inventory Days
141
Payable Days
121
120
Debt to Equity (x)
0.15x
Interest Coverage (x)
4.11x
1.88x
Revenue Growth %
0.10%
Operating Profit Growth %
-11.87%
Net Profit Growth %
-42.83%
-46.76%
P/E (x)
104.07x
P/B (x)
2.53x
Dividend Yield %
0.09%
49.56x
Mar 2025
EPS (₹)
8.80
Book Value (₹)
233.62
Dividend per Share (₹)
0.50
Cash EPS (₹)
14.33
Operating Margin %
17.74%
Net Margin %
9.29%
ROE %
3.83%
ROCE %
4.65%
2.84%
Debtor Days
72
Inventory Days
120
Payable Days
89
103
Debt to Equity (x)
0.19x
Interest Coverage (x)
3.15x
1.53x
Revenue Growth %
59.30%
Operating Profit Growth %
51.96%
Net Profit Growth %
60.57%
58.64%
P/E (x)
71.13x
P/B (x)
2.68x
Dividend Yield %
0.08%
36.21x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
47.95
2.15
0.88
Government
0.00
49.01
Sep 2024
47.95
2.16
0.88
Government
0.00
47.88
Dec 2024
47.95
3.21
0.88
Government
0.00
46.83
Mar 2025
47.37
3.17
0.64
Government
0.00
47.71
Jun 2025
47.37
3.25
0.56
Government
0.00
47.71
Sep 2025
47.37
3.27
0.48
Government
0.00
47.77
Dec 2025
47.37
3.36
0.12
Government
0.00
48.61
Mar 2026
47.37
3.66
0.00
Government
0.00
48.42
Jun 2026
47.37
0.66
0.02
Government
0.00
51.41

Documents

Announcements

  • Shareholders meeting

    2026-08-21 - Shivalik Rasayan Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on August 20, 2026

  • Copy of Newspaper Publication

    2026-08-17 - Shivalik Rasayan Limited has informed the Exchange about Copy of Newspaper Publication

Annual Reports

Nothing filed yet.

Credit Ratings

Nothing filed yet.

Concalls

  • Nov 2024

    TranscriptPPTREC
  • Dec 2021

    TranscriptPPTREC
  • Sep 2021

    TranscriptPPTREC